Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 988 | 1003 | 1046 | 915 | 957 | 1085 |
Fund Return | -1.2% | 0.26% | 4.56% | -2.91% | -0.87% | 0.82% |
Place in category | 1543 | 1476 | 1247 | 955 | 679 | 277 |
% in Category | 95 | 89 | 76 | 72 | 60 | 38 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Raiffeisen 304 Euro Corporate VWG V | 500.31M | -1.20 | -2.91 | 0.82 | ||
Raiffeisen 304 Euro Corporates A | 500.31M | -1.21 | -2.92 | 0.82 | ||
UNIQA Eastern European Debt Fund A | 337.7M | -0.86 | -7.92 | 0.13 | ||
UNIQA Eastern European Debt Fund VT | 337.7M | -0.86 | -7.92 | 0.12 | ||
Raiffeisen Euro Rent R A | 318.68M | 2.88 | -6.20 | 0.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Raiffeisen 304 Euro Corporate VWG V | 500.31M | -1.20 | -2.91 | 0.82 | ||
Raiffeisen 304 Euro Corporates A | 500.31M | -1.21 | -2.92 | 0.82 | ||
Sirius 25 I A | 251.32M | -1.05 | -2.11 | 1.47 | ||
3 Banken Unternehmensanleihen FondA | 306.57M | 0.18 | -2.35 | 0.74 | ||
3 Banken Unternehmensanleihen Fonds | 306.57M | 0.13 | -2.34 | 0.73 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Euro-Schatz-Future | - | 5.54 | - | - | |
Euro-Bobl-Future | - | 1.61 | - | - | |
Germany 0.4 13-Sep-2024 | DE0001104891 | 1.53 | 99.240 | -0.01% | |
Novo Nordisk Finance (Netherlands) B.V. 0% | XS2348030268 | 0.83 | - | - | |
DTEGF 7.5 24-Jan-2033 | XS0161488498 | 0.69 | 128.73 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | BUY | Strong Buy |
Summary | Buy | Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review